annual D&A:
$10.29M+$1.31M(+14.58%)Summary
- As of today (July 27, 2025), NTLA annual depreciation & amortization is $10.29 million, with the most recent change of +$1.31 million (+14.58%) on December 31, 2024.
- During the last 3 years, NTLA annual D&A has risen by +$3.39 million (+49.25%).
- NTLA annual D&A is now at all-time high.
Performance
NTLA Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$2.50M-$68.00K(-2.65%)Summary
- As of today (July 27, 2025), NTLA quarterly depreciation & amortization is $2.50 million, with the most recent change of -$68.00 thousand (-2.65%) on March 31, 2025.
- Over the past year, NTLA quarterly D&A has dropped by -$14.00 thousand (-0.56%).
- NTLA quarterly D&A is now -4.22% below its all-time high of $2.61 million, reached on September 30, 2024.
Performance
NTLA quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$10.27M-$14.00K(-0.14%)Summary
- As of today (July 27, 2025), NTLA TTM depreciation & amortization is $10.27 million, with the most recent change of -$14.00 thousand (-0.14%) on March 31, 2025.
- Over the past year, NTLA TTM D&A has increased by +$833.00 thousand (+8.83%).
- NTLA TTM D&A is now -0.14% below its all-time high of $10.29 million, reached on December 31, 2024.
Performance
NTLA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NTLA Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.6% | -0.6% | +8.8% |
| 3 y3 years | +49.3% | +42.4% | +45.6% |
| 5 y5 years | +84.1% | +62.1% | +69.6% |
NTLA Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.3% | -4.2% | +36.0% | -0.1% | +41.5% |
| 5 y | 5-year | at high | +84.1% | -4.2% | +59.5% | -0.1% | +69.6% |
| alltime | all time | at high | +3035.7% | -4.2% | +7469.7% | -0.1% | >+9999.0% |
NTLA Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $2.50M(-2.7%) | $10.27M(-0.1%) |
| Dec 2024 | $10.29M(+14.6%) | $2.57M(-1.6%) | $10.29M(+1.0%) |
| Sep 2024 | - | $2.61M(+0.3%) | $10.19M(+3.2%) |
| Jun 2024 | - | $2.60M(+3.5%) | $9.87M(+4.5%) |
| Mar 2024 | - | $2.51M(+1.9%) | $9.44M(+5.1%) |
| Dec 2023 | $8.98M(+18.5%) | $2.47M(+7.7%) | $8.98M(+5.1%) |
| Sep 2023 | - | $2.29M(+5.5%) | $8.54M(+4.1%) |
| Jun 2023 | - | $2.17M(+5.9%) | $8.20M(+4.2%) |
| Mar 2023 | - | $2.05M(+0.9%) | $7.87M(+3.9%) |
| Dec 2022 | $7.57M(+9.9%) | $2.03M(+4.2%) | $7.57M(+2.0%) |
| Sep 2022 | - | $1.95M(+6.2%) | $7.42M(+2.3%) |
| Jun 2022 | - | $1.84M(+4.7%) | $7.26M(+2.9%) |
| Mar 2022 | - | $1.75M(-6.7%) | $7.05M(+2.4%) |
| Dec 2021 | $6.89M(+9.2%) | $1.88M(+5.3%) | $6.89M(+4.2%) |
| Sep 2021 | - | $1.79M(+9.3%) | $6.61M(+2.9%) |
| Jun 2021 | - | $1.63M(+2.7%) | $6.43M(+1.1%) |
| Mar 2021 | - | $1.59M(-0.7%) | $6.36M(+0.8%) |
| Dec 2020 | $6.31M | $1.60M(0.0%) | $6.31M(+0.6%) |
| Sep 2020 | - | $1.60M(+2.3%) | $6.28M(+3.6%) |
| Jun 2020 | - | $1.57M(+1.6%) | $6.06M(+3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $1.54M(-1.6%) | $5.83M(+4.3%) |
| Dec 2019 | $5.59M(+25.2%) | $1.57M(+13.2%) | $5.59M(+6.5%) |
| Sep 2019 | - | $1.38M(+3.4%) | $5.25M(+4.6%) |
| Jun 2019 | - | $1.34M(+2.9%) | $5.02M(+5.6%) |
| Mar 2019 | - | $1.30M(+5.9%) | $4.75M(+6.5%) |
| Dec 2018 | $4.46M(+49.1%) | $1.23M(+6.5%) | $4.46M(+9.7%) |
| Sep 2018 | - | $1.15M(+7.4%) | $4.07M(+9.8%) |
| Jun 2018 | - | $1.07M(+6.0%) | $3.71M(+10.8%) |
| Mar 2018 | - | $1.01M(+21.5%) | $3.35M(+11.8%) |
| Dec 2017 | $2.99M(+171.2%) | $833.00K(+5.4%) | $2.99M(+16.7%) |
| Sep 2017 | - | $790.00K(+11.1%) | $2.57M(+25.7%) |
| Jun 2017 | - | $711.00K(+7.7%) | $2.04M(+29.4%) |
| Mar 2017 | - | $660.00K(+63.0%) | $1.58M(+42.8%) |
| Dec 2016 | $1.10M(+236.6%) | $405.00K(+52.8%) | $1.10M(+32.9%) |
| Sep 2016 | - | $265.00K(+7.3%) | $831.00K(+25.5%) |
| Jun 2016 | - | $247.00K(+32.1%) | $662.00K(+37.3%) |
| Mar 2016 | - | $187.00K(+41.7%) | $482.00K(+47.0%) |
| Dec 2015 | $328.00K | $132.00K(+37.5%) | $328.00K(+67.3%) |
| Sep 2015 | - | $96.00K(+43.3%) | $196.00K(+96.0%) |
| Jun 2015 | - | $67.00K(+103.0%) | $100.00K(+203.0%) |
| Mar 2015 | - | $33.00K | $33.00K |
FAQ
- What is Intellia Therapeutics, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual D&A year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Intellia Therapeutics, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. TTM D&A year-on-year change?
What is Intellia Therapeutics, Inc. annual depreciation & amortization?
The current annual D&A of NTLA is $10.29M
What is the all time high annual D&A for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual depreciation & amortization is $10.29M
What is Intellia Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, NTLA annual depreciation & amortization has changed by +$1.31M (+14.58%)
What is Intellia Therapeutics, Inc. quarterly depreciation & amortization?
The current quarterly D&A of NTLA is $2.50M
What is the all time high quarterly D&A for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly depreciation & amortization is $2.61M
What is Intellia Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, NTLA quarterly depreciation & amortization has changed by -$14.00K (-0.56%)
What is Intellia Therapeutics, Inc. TTM depreciation & amortization?
The current TTM D&A of NTLA is $10.27M
What is the all time high TTM D&A for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high TTM depreciation & amortization is $10.29M
What is Intellia Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, NTLA TTM depreciation & amortization has changed by +$833.00K (+8.83%)